相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cost-effectiveness of cenobamate for focal seizures in people with drug-resistant epilepsy
Vicki Laskier et al.
EPILEPSIA (2023)
Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain
Vicente Villanueva et al.
EPILEPSY & BEHAVIOR (2023)
Seizure- or Epilepsy-Related Emergency Department Visits Before and During the COVID-19 Pandemic — United States, 2019–2021
Sanjeeb Sapkota et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
Pavel Klein et al.
NEUROLOGY (2022)
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain
Miguel Angel Calleja et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2022)
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study
Michael R. Sperling et al.
EPILEPSIA (2021)
Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome
J. Helen Cross et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)
Highlights From AES2020, a Virtual American Epilepsy Society Experience
Barbara C. Jobst et al.
EPILEPSY CURRENTS (2021)
Raising the bar: Fenfluramine sets new treatment standards for Dravet syndrome
Joseph Sullivan et al.
EPILEPSY & BEHAVIOR (2021)
Suicidality Risk of Newer Antiseizure Medications A Meta-analysis
Pavel Klein et al.
JAMA NEUROLOGY (2021)
Seizure freedom as an outcome in epilepsy treatment clinical trials
Jonathan J. Halford et al.
ACTA NEUROLOGICA SCANDINAVICA (2020)
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens A Randomized Clinical Trial
Rima Nabbout et al.
JAMA NEUROLOGY (2020)
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study
Michael R. Sperling et al.
EPILEPSIA (2020)
The feast and famine: Epilepsy treatment and treatment gaps in early 21st century
Wolfgang Loescher et al.
NEUROPHARMACOLOGY (2020)
Fenfluramine HCl (Fintepla(R)) provides long-term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open-label extension study
Joseph Sullivan et al.
EPILEPSIA (2020)
Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs A 30-Year Longitudinal Cohort Study
Zhibin Chen et al.
JAMA NEUROLOGY (2018)
The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis
Linda Kalilani et al.
EPILEPSIA (2018)
The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy
David J. Thurman et al.
EPILEPSIA (2017)
Recognizing and preventing epilepsy-related mortality A call for action
Orrin Devinsky et al.
NEUROLOGY (2016)
Mortality in Dravet syndrome
Monica S. Cooper et al.
EPILEPSY RESEARCH (2016)
Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
Elinor Ben-Menachem et al.
NEUROLOGY (2016)
A reappraisal of mortality after epilepsy surgery
Michael R. Sperling et al.
NEUROLOGY (2016)
The incidence of SCN1A-related Dravet syndrome in Denmark is 1: 22,000: A population-based study from 2004 to 2009
Allan Bayat et al.
EPILEPSIA (2015)
Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies
Bernhard J. Steinhoff et al.
EPILEPSIA (2013)
Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials
Philippe Ryvlin et al.
LANCET NEUROLOGY (2011)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)